8.38 Delayed Data As of Apr 20 | ![]() Today’s Change | 4.67 Today|||52-Week Range 8.39 | +33.44% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $329.8M |
Clinuvel Pharmaceuticals Ltd. 190 Queen Street Melbourne Victoria (vic) 3000 |
Philippe J. Wolgen | Chief Executive Officer, Director & MD |
Darren M. Keamy | Chief Financial Officer & Secretary |
Dennis J. Wright | Chief Scientific Officer |